Shuttle Pharmaceuticals Holdings (SHPH) Accumulated Expenses (2022 - 2025)

Shuttle Pharmaceuticals Holdings has reported Accumulated Expenses for 4 years, with the latest figure at $7854.0 in Q3 2025.

• On a quarterly basis, Accumulated Expenses rose 267.52% year-over-year to $7854.0 in Q3 2025; TTM through Sep 2025 was $7854.0, a 267.52% increase from a year earlier, with the FY2024 full-year figure at $1785.0, down 98.38% from the prior year.
• Accumulated Expenses was $7854.0 for Q3 2025 at Shuttle Pharmaceuticals Holdings, up from $7753.0 in the prior quarter.
• The five-year high for Accumulated Expenses was $143676.0 in Q1 2024, with the low at $822.0 in Q3 2022.
• Average Accumulated Expenses over 4 years is $55121.8, with a median of $23328.0 recorded in 2023.
• The sharpest annual moves came in 2023 and 2024: Accumulated Expenses surged 12865.69% in 2023, then tumbled 98.38% in 2024.
• Over 4 years, Accumulated Expenses stood at $98135.0 in 2022, then advanced by 12.55% to $110453.0 in 2023, then sank by 98.38% to $1785.0 in 2024, then surged by 340.0% to $7854.0 in 2025.
• The last three Accumulated Expenses figures came in at $7854.0 (Q3 2025), $7753.0 (Q2 2025), and $7653.0 (Q1 2025), per Business Quant data.